Roger Aitchison

1.9k citations

20 papers · 1.4k indexed · 1 hit paper · h-index 11

Impact in

Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Hematology top 2%
- Autoimmune and Inflammatory Disorders Research

Papers in

Hematology 5
- Multiple Myeloma Research and Treatments 3
Immunology 6
- Immune Response and Inflammation 3

Co-authors: Barry Bresnihan Dorothy McCabe Iain Watt Mark Cobby Bryan Williams Karel Pavelká Rolf Rau Predrag Musikic
Journals: Open Forum Infectious Diseases (3 papers)Journal of Clinical Oncology (2 papers)The Journal of Infectious Diseases (2 papers)Clinical Infectious Diseases (1 paper)Radiology (1 paper)
Partner nations: United States United Kingdom Spain

In The Last Decade

Roger Aitchison

20 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist 1998 · 767 citations

Peers

Countries citing papers authored by Roger Aitchison

Since Specialization

Citations

This map shows the geographic impact of Roger Aitchison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Aitchison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Aitchison more than expected).

Fields of papers citing papers by Roger Aitchison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Aitchison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Aitchison. The network helps show where Roger Aitchison may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Roger Aitchison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roger Aitchison Line = papers co-authored together Roger Aitchison links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65–85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trial The Lancet Infectious Diseases ·Joseph Eiden, Carlos Fierro, Alexander White, Matthew C. Davis, Margaret Rhee, Mark Turner, Katherine Trudeau, Renee Herber, Roger Aitchison, David Marshall, Michael J. Moser, Robert B. Belshe, Harry B. Greenberg, Kathleen Coelingh, Yoshihiro Kawaoka, Gabriele Neumann, Pamuk Bilsel	2024	5
2	Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults The Journal of Infectious Diseases ·Joseph E. Eiden, Carlos Fierro, Howard Schwartz, Mark Adams, C. Ryan Manzer, Roger Aitchison, Renee Herber, Yasuko Hatta, David Marshall, Michael J. Moser, Robert B. Belshe, Harry B. Greenberg, Kathleen Coelingh, Yoshihiro Kawaoka, Gabriele Neumann, Pamuk Bilsel	2022	14
3	M2-Deficient Single-Replication Influenza Vaccine–Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain The Journal of Infectious Diseases ·Joseph E. Eiden, M Nautet, zhipeng zheng, Roger Aitchison, Renee Herber, Robert B. Belshe, Harry B. Greenberg, Kathleen Coelingh, David Marshall, Yoshihiro Kawaoka, Gabriele Neumann, Pamuk Bilsel	2021	18
4	Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults Vaccines ·Joseph E. Eiden, Brandon Thomas Crowley, Carlos Fierro, Renee Herber, Roger Aitchison, Robert B. Belshe, Harry B. Greenberg, Daniel F. Hoft, Yasuko Hatta, Michael J. Moser, Magdalena Tary‐Lehmann, Yoshihiro Kawaoka, Gabriele Neumann, J.P. de Kort, Pamuk Bilsel	2021	8
5	33. Intranasal M2SR (M2-deficient Single Replication) Live H3N2 Influenza Investigational Vaccine Induces Serum HAI & Broad Immune Responses in High Proportion of Adults Open Forum Infectious Diseases ·Joseph E. Eiden, Ruth D. Ellis, Carlos Fierro, Howard Schwartz, Mark E. Adams, 昭吉阿部, Roger Aitchison, Renee Herber, Pamuk Bilsel	2020	2
6	Optoacoustic Imaging and Gray-Scale US Features of Breast Cancers: Correlation with Molecular Subtypes Radiology ·Başak E. Doğan, Gisela L. G. Menezes, Reni Butler, Erin Neuschler, Roger Aitchison, Philip T. Lavin, F. Lee Tucker, Stephen R. Grobmyer, Pamela Otto, A. Thomas Stavros	2019	46
7	2748. Single Intranasal (IN) Dose of M2SR (M2-Deficient Single Replication) Live Influenza Vaccine Protects Adults Against Subsequent Challenge with a Substantially Drifted H3N2 Strain Open Forum Infectious Diseases ·Joseph Eiden, M Nautet, zhipeng zheng, Ruth D. Ellis, Roger Aitchison, Renee Herber, Robert B. Belshe, Harry B. Greenberg, Kathleen Coelingh, Yoshihiro Kawaoka, Gabriele Neumann, Pamuk Bilsel	2019	2
8	Locking Hemodialysis Catheters With Trimethoprim-Ethanol-Ca-EDTA to Prevent Bloodstream Infections: A Randomized, Evaluator-blinded Clinical Trial Clinical Infectious Diseases ·Bart Rijnders, G.I. Andreev, Botond Csiky, Piotr Rutkowski, Krzysztof Appelt, John C. Cheronis, Roger Aitchison, Grant Stevens, Michel Jadoul, Richard Fluck	2018	12
9	1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults Open Forum Infectious Diseases ·Joseph E. Eiden, Brandon Thomas Crowley, Carlos Fierro, Robert B. Belshe, Harry B. Greenberg, Zeba Mueed, Yasuko Hatta, Michael Imboden, Mike Moser, Renee Herber, David A. Boltz, Magdalena Tary‐Lehmann, Yoshihiro Kawaoka, Gabriele Neumann, J.P. de Kort, Roger Aitchison, Pamuk Bilsel	2018	1
10	The AfFIRM Study: A multicenter phase 2 study of single-agent filanesib (ARRY-520) in patients with advanced multiple myeloma. Journal of Clinical Oncology ·Sagar Lonial, Michel Delforge, Hermann Einsele, Philippe Moreau, Martin Kaiser, Meletios Α. Dimopoulos, Albert Oriol, M Gyger, Brandi Hilder, H. Siev�nen, Roger Aitchison, Robert Z. Orlowski	2015	2
11	A multicenter, randomized, open-label, phase 2 study of carfilzomib with or without ARRY-520 (filanesib) in patients with advanced multiple myeloma. Journal of Clinical Oncology ·Jeffrey A. Zonder, Noopur Raje, Emma C. Scott, Craig C. Hofmeister, Nikoletta Lendvai, Larry D. Anderson, Parameswaran Hari, Gregory Orloff, Jesús G. Berdeja, Seema Singhal, Michael Craig, Jason Valent, Mieke Ptaszynski, Giry Eric, Roger Aitchison, Saad Z. Usmani	2015	1
12	Safety and Efficacy Of ARRY-502, a Potent, Selective, Oral CRTh2 Antagonist, In Patients With Mild To Moderate Th2-Driven Asthma Journal of Allergy and Clinical Immunology ·Sally E. Wenzel, Robert W. Hopkins, Michael D. Saunders, David Chantry, Lisa Anderson, Roger Aitchison, Yiling Wang, Stacie Bell, Jeremy Cole, James Wolfe, Sheldon L. Spector, Lawrence Sher, Edward Kerwin, H Macera	2014	14
13	Evaluation of the siRNA PF-04523655 versus Ranibizumab for the Treatment of Neovascular Age-related Macular Degeneration (MONET Study) Ophthalmology ·Quan Dong Nguyen, Ronald A. Schachar, Chudy I. Nduaka, Zou Qiu-juan, Karen J. Klamerus, 옥태준, Ramabhadran S. Thirumalai, Dario A. Paggiarino, Irit Rosenblatt, Roger Aitchison, Shai Erlich	2012	70
14	Intra-anal Iferanserin 10 mg BID for Hemorrhoid Disease: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Clinical Therapeutics ·Alexander Herold, John W. Dietrich, Roger Aitchison	2012	4
15	Dose-Ranging Evaluation of Intravitreal siRNA PF-04523655 for Diabetic Macular Edema (the DEGAS Study) Investigative Ophthalmology & Visual Science ·Quan Dong Nguyen, Ronald A. Schachar, Chudy I. Nduaka, Zou Qiu-juan, Anthony S. Basile, Karen J. Klamerus, 옥태준, Ramabhadran S. Thirumalai, Dario A. Paggiarino, Irit Rosenblatt, Roger Aitchison, Shai Erlich	2012	83
16	Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors Cancer Chemotherapy and Pharmacology ·Hiroyuki Kobayashi, S. Gail Eckhardt, Jennifer A. Lockridge, Mace L. Rothenberg, Alan B. Sandler, Cindy L. O’Bryant, Wendy Cooper, Scott N. Holden, Roger Aitchison, Nassim Usman, Carlos Alberto Schettino Júnior, M. Basche	2005	28
17	A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: Radiologic progression and correlation of genant and larsen scores Arthritis & Rheumatism ·Yebin Jiang, Harry K. Genant, Iain Watt, Mark Cobby, Barry Bresnihan, Roger Aitchison, Dorothy McCabe	2000	304
18	Reply Arthritis & Rheumatism ·Barry Bresnihan, Rawal lab, Mark Cobby, Michael Doherty, Z Domljan, Paul Emery, George Nuki, Karel Pavelká, Rolf Rau, Blaž Rozman, Iain Watt, Bryan Williams, Roger Aitchison, Dorothy McCabe, Predrag Musikic	1999	1
19	Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist Arthritis & Rheumatism ·Barry Bresnihan, José María Álvaro‐Gracia, Mark Cobby, Michael Doherty, Z Domljan, Paul Emery, George Nuki, Karel Pavelká, Rolf Rau, Blaž Rozman, Iain Watt, Bryan Williams, Roger Aitchison, Dorothy McCabe, Predrag Musikic	1998	65
20	Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist Arthritis & Rheumatism ·Barry Bresnihan, Caroline Emig, Mark Cobby, Michael Doherty, Z Domljan, Paul Emery, George Nuki, Karel Pavelká, Rolf Rau, Blaž Rozman, Iain Watt, Bryan Williams, Roger Aitchison, Dorothy McCabe, Predrag Musikic Hit paper breakdown →	1998	767

About Roger Aitchison

Roger Aitchison is a scholar working on Hematology, Immunology, Rheumatology, Epidemiology and Ophthalmology, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (7 papers), Respiratory viral infections research (4 papers), Pneumonia and Respiratory Infections (3 papers), Multiple Myeloma Research and Treatments (3 papers), Protein Degradation and Inhibitors (3 papers), Immune Response and Inflammation (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Retinal Diseases and Treatments (2 papers). The work is most often cited by research in Rheumatology (754 citations), Hematology (393 citations), Immunology (366 citations), Radiology, Nuclear Medicine and Imaging (212 citations) and Genetics (84 citations). Roger Aitchison has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Barry Bresnihan, Dorothy McCabe, Iain Watt, Mark Cobby, Bryan Williams, Karel Pavelká, Rolf Rau, Predrag Musikic, Z Domljan and George Nuki. Their work appears in journals such as Open Forum Infectious Diseases, Journal of Clinical Oncology, The Journal of Infectious Diseases, Clinical Infectious Diseases and Radiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact